Mark Eisner, EVP, Chief Medical Officer: Kyntra Bio KYNB Sell · Filed 23/06/09

Trade details

Type: Insider sale
Amount: $34,795.68
Shares · price: 2,042 sh · $17.04 a share
Held after: 162,862 sh
Stock: Kyntra Bio KYNB
Person: Mark EisnerEVP, Chief Medical Officer
Trade date: 23/06/07
Filed: 23/06/09
Days to filing: 2 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Kyntra Bio trades, last 26 weeks

What else happened in Kyntra Bio around then

Filed or reported within 30 days of the trade day · 23/05/08~23/07/07

Mark Eisner's recent trades

Mark EisnerFormer Officer
Planned saleVir Biotechnology
Planned sale
Vir Biotechnology
VIR
$916.3K
88,958 sh
$916.3K
Filed 04/30
Traded 04/30
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$18.5K
1,889 sh
$18.5K
Filed 02/26
Traded 02/25
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$15.4K
1,616 sh
$15.4K
Filed 02/26
Traded 02/24
Mark EisnerOfficer
Planned sale10b5-1 planVir Biotechnology
Planned sale10b5-1 plan
Vir Biotechnology
VIR
$18.5K
1,889 sh
$18.5K
Filed 02/25
Traded 02/25
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$15.6K
2,089 sh
$15.6K
Filed 02/24
Traded 02/23